Mutares SE & Co. KGaA (LON:0UTK)
28.30
+0.20 (0.71%)
At close: Oct 28, 2025
Mutares SE & Co. KGaA Revenue
Mutares SE & Co. KGaA had revenue of 1.61B EUR in the quarter ending June 30, 2025, with 24.02% growth. This brings the company's revenue in the last twelve months to 5.81B, up 14.56% year-over-year. In the year 2024, Mutares SE & Co. KGaA had annual revenue of 5.32B with 12.63% growth.
Revenue (ttm)
5.81B EUR
Revenue Growth
+14.56%
P/S Ratio
0.11
Revenue / Employee
200.42K EUR
Employees
29,000
Market Cap
523.63M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.32B | 596.70M | 12.63% |
| Dec 31, 2023 | 4.72B | 956.60M | 25.39% |
| Dec 31, 2022 | 3.77B | 1.25B | 49.64% |
| Dec 31, 2021 | 2.52B | 927.40M | 58.32% |
| Dec 31, 2020 | 1.59B | 569.60M | 55.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |